The odds of RFK Jr. implementing a ban on TV drug ads are slim, says our guest this week, BranchLab’s Josh Walsh. Still, pharma advertisers could face other regulatory changes over the next four years. Plus: We break down Forrester’s picks for the top 10 SSPs.

The odds of RFK Jr. implementing a ban on TV drug ads are slim, says our guest this week, BranchLab’s Josh Walsh. Still, pharma advertisers could face other regulatory changes over the next four years. Plus: We break down Forrester’s picks for the top 10 SSPs.

The odds of RFK Jr. implementing a ban on TV drug ads are slim, says our guest this week, BranchLab’s Josh Walsh. Still, pharma advertisers could face other&nbsp;regulatory changes over the next four years. Plus: We break down Forrester’s picks for the top 10 SSPs.

No More TV Drug Ads? Don’t Hold Your Breath

Each week, the AdExchanger editorial team drills into the week's most urgent headlines in digital marketing. Hosted by Executive Editor Sarah Sluis, this podcast gets listeners up to speed on the most pressing news in ad tech and beyond, with key background details and analysis.

Share No More TV Drug Ads? Don’t Hold Your Breath

Sign up to save your podcasts

No More TV Drug Ads? Don’t Hold Your Breath

No More TV Drug Ads? Don’t Hold Your Breath

More shows like The Big Story

Decoder with Nilay Patel

Odd Lots

Pivot

Channels with Peter Kafka

AdExchanger

Equity

Masters of Scale

The CMO Podcast

The Prof G Pod with Scott Galloway

Hard Fork

Marketecture: Get Smart. Fast.

On with Kara Swisher

Sharp Tech with Ben Thompson

AdTechGod Pod

Prof G Markets